NM_194272.3:c.406G>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_194272.3(RBPMS2):c.406G>A(p.Ala136Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A136S) has been classified as Uncertain significance.
Frequency
Consequence
NM_194272.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000637 AC: 16AN: 251286 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461854Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74462 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.406G>A (p.A136T) alteration is located in exon 5 (coding exon 5) of the RBPMS2 gene. This alteration results from a G to A substitution at nucleotide position 406, causing the alanine (A) at amino acid position 136 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at